Positive antiphospholipid antibodies raises cardiovascular disease risk in patients with systemic lupus erythematosus

by

New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE).

Leave A Comment

Your email address will not be published. Required fields are marked *